(Q71396788)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8757358%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

title

Comparison of once-daily versus pharmacokinetic dosing of aminoglycosides in elderly patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8757358%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

1 reference

J Koo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8757358%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

R Tight

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8757358%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

V Rajkumar

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8757358%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

Z Hawa

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8757358%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

publication date

1 August 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8757358%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Medicine

18 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8757358%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

volume

101

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8757358%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8757358%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

page(s)

177-183

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8757358%20AND%20SRC:MED&resulttype=core&format=json

A study of amikacin given once versus twice daily in serious infections

18 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980074-X

Once versus thrice daily gentamicin in patients with serious infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980074-X

Does administration of an aminoglycoside in a single daily dose affect its efficacy and toxicity?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980074-X

Once-daily dosing regimen for aminoglycoside plus beta-lactam combination therapy of serious bacterial infections: comparative trial with netilmicin plus ceftriaxone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980074-X

Netilmicin in the treatment of gram-negative bacteremia: single daily versus multiple daily dosage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980074-X

A multicentric study of netilmicin once daily versus thrice daily in patients with appendicitis and other intra-abdominal infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980074-X

Once daily administration of netilmicin compared with thrice daily, both in combination with metronidazole, in gangrenous and perforated appendicitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980074-X

Comparative kinetics and efficacy of amikacin administered once or twice daily in the treatment of systemic gram-negative infections.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980074-X

Efficacy and toxicity of single daily doses of amikacin and ceftriaxone versus multiple daily doses of amikacin and ceftazidime for infection in patients with cancer and granulocytopenia. The International Antimicrobial Therapy Cooperative Group of t

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980074-X

Once-daily versus thrice-daily dosing of netilmicin in combination with beta-lactam antibiotics as empirical therapy for febrile neutropenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980074-X

Pharmacodynamic parameters and toxicity of netilmicin (6 milligrams/kilogram/day) given once daily or in three divided doses to cancer patients with urinary tract infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980074-X

Predictability of blood levels of gentamicin in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980074-X

The unpredictability of serum concentrations of gentamicin: pharmacokinetics of gentamicin in patients with normal and abnormal renal function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980074-X

Gentamicin pharmacokinetics in 1,640 patients: method for control of serum concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980074-X

APACHE II: a severity of disease classification system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980074-X

A critical reevaluation of the "therapeutic range" of aminoglycosides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980074-X

Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: gentamicin in burn patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980074-X

Kinetic model for gentamicin dosing with the use of individual patient parameters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980074-X

Aminoglycoside nephrotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980074-X

Gentamicin blood levels: a guide to nephrotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980074-X

Controlled Comparison of Gentamicin and Tobramycin Nephrotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980074-X

10.1016/S0002-9343(96)80074-X

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8757358%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

1 reference